since this thread is here, figured i'd add a little info ...has been on a decline for a long time due to poor management/debt etc but company seems to be trying to pull it together.... recently made a good move from under 01 and seems to be picking up more buying but vol is still low... imo if/when company begins to advertise more, which they seem to be maybe in the process of doing, and if they release even half way decent news more consistently then this will probably make a bigger move, so some may wanna keep it on watch b/c when it moves it can move up pretty quick, or it used to anyway lol...
Company Details
CalbaTech, Inc.. The Group's principal activities are to provide products and platforms to the life sciences research market, both for biotech and pharmaceutical companies. The customers include federally funded research centers, supply stores, university and private research centers, medical distributors and Original Equipment Manufacturers.
Shares Outstanding- 121.3M
Market Cap - 2.7M
Company Website -
www.calbatech.com
CLBE Companies
Life Stem -
http://www.life-stem.com
KD Medical -
http://www.kdmedical.com/
MoleculA -
http://www.molecula.com/
Solona MedSpas -
http://www.solanamedspas.com/home_B.htm
-----------------------------------------------------------------------------------------------------------------------------------------------------------
8/14/07 financials - not great but getting better -
http://www.sec.gov/Archives/edgar/da...081407woex.txt
Life Stem - full page add on pg 3 and article starts on pg 16 -
http://atlantalifemag.epubxpress.com/
Benitec MOU With CalbaTech, Inc.
Thursday August 16, 11:54 am ET
Stem cell storage service connected with potential Benitec HIV therapy
MELBOURNE, Australia, Aug 16. /PRNewswire-FirstCall/ -- Benitec Limited (ASX: BLT - News) has signed a Memorandum of Understanding with California-based CalbaTech, Inc. (OTC Bulletin Board: CLBE - News) to provide stem cell storage services for US HIV patients who may use the healthy adult (or "blood" or "hematopoietic") stem cells in future therapy.
ADVERTISEMENT
Benitec has collaborated with City of Hope, a biomedical research and treatment center, in the development of a possible HIV therapeutic. This investigational HIV therapeutic creates the possibility that an adult (or "blood" or "hematopoietic") stem cell based therapeutic may be able to take the place of anti-retroviral medication. Early banking of adult (or "blood" or "hematopoietic") stem cells by HIV sufferers may be very prudent if a stem cell therapy is approved by the FDA after the conclusion of clinical trials.
This potential therapy surrounds a newly discovered possible way in which to fight HIV, the virus that causes AIDS, with genetically modified adult (or "blood" or "hematopoietic") stem cells. The potential therapeutic may emerge as the first to use specially engineered, HIV-fighting genes that are inserted into patients' own harvested adult (or "blood" or "hematopoietic") stem cells. After re-infusion into the patient, the new treatment may allow patients' bodies to produce HIV-resistant white blood cells indefinitely.
Benitec's MOU with CalbaTech would provide, in the short term, that Benitec would receive fees for stem cell storage performed by CalbaTech's subsidiary, TherapyStem, Inc. In the longer term, both Benitec and CalbaTech are encouraged that this potential new therapeutic will develop an effective HIV therapeutic that relies on healthy adult (or "blood" or "hematopoietic") stem cells. CalbaTech believes that, in the future, as this potential therapeutic develops, TherapyStem will be able to treat the cells that have been banked by HIV patients and send those treated cells to a patient's treating physician for re-injection. CalbaTech would pay to Benitec a fee for using the protocols developed for the treatment of the stem cells.
CalbaTech's new subsidiary, TherapyStem, Inc., has created a patent-pending., process to harvest stem cells from HIV infected individuals to be cryopreserved for future transplantation into a client for medical purposes. All other stem cell collection services exclude the collection, processing and storage of blood from individuals with HIV. As the business of TherapyStem develops, the company also believes that it will be able to collect, process and store stem cells from umbilical cords that have come from a mother that has HIV. Those cords are currently excluded from collection by cord blood companies.
CLBE - CalbaTech, Inc
Linear Mode
